Lymph Tone
- Manufacturer
- Energetix Corp | OHM PHARMA INC.
- Effective date
- 2017-01-04
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 3
- Source
- full-release
- Hydrated at
- 2026-06-01 02:08:30
Label at a glance#
ProductLymph Tone II
Active ingredientHORSE CHESTNUT, AZADIRACHTA INDICA BARK, BARIUM CARBONATE, BERBERIS VULGARIS ROOT BARK, PEUMUS BOLDUS LEAF, BUFO BUFO CUTANEOUS GLAND, OYSTER SHELL CALCIUM CARBONATE, CRUDE, TRIBASIC CALCIUM PHOSPHATE, COENZYME A, COLLINSONIA CANADENSIS ROOT, ECHINACEA ANGUSTIFOLIA, FERRUM PHOSPHORICUM, SUS SCROFA ADRENAL GLAND, BOS TAURUS HYPOTHALAMUS, WOOD CREOSOTE, NADIDE, SODIUM CHLORIDE, PHOSPHORUS, PHYTOLACCA AMERICANA ROOT, PINUS SYLVESTRIS LEAFY TWIG, BOS TAURUS PITUITARY GLAND, PINE TAR, PULSATILLA VULGARIS, SILICON DIOXIDE, STILLINGIA SYLVATICA ROOT, THUJA OCCIDENTALIS LEAFY TWIG
Label structure10 sections
Contacts and useful links#
Websitewww.goenergetix.com
www.goenergetix.com
www.goenergetix.comLabel contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active ingredients (per drop)
Aesculus hipp 12X; Azadirachta 8X; Baryta carb 12X; Berber vulg 12X; Boldo 4X, 12X; Bufo 12X; Calc carb 12X; Calc phos 12X; Coenzyme A 12X, 30X; Collinsonia 10X; Echinacea 6X; Ferrum phos 12X; Glandula suprarenalis suis 9X, 12X, 6C; Hypothalamus 12X, 6C; Kreosotum 15X; Nadidum 12X, 30X; Nat mur 12X; Phos 30X; Phytolacca 4X; Pinus syl 9X; Pituitarum posterium 12X, 6C; Pix liquida 6X; Pulsatilla 12X; Silicea 12X; Stillingia 4X; Thuja occ 12X.
Purpose
Temporary relief of migrating pains, skin eruptions, fatigue, swollen glands.
INDICATIONS & USAGE SECTION
Uses
Temporary relief of migrating pains, skin eruptions, fatigue, swollen glands.
WARNINGS SECTION
Warnings
- In case of overdose, get medical help or contact a Poison Control Center right away.
- If pregnant or breast feeding, ask a health professional before use.
- Keep out of reach of children.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.
DOSAGE & ADMINISTRATION SECTION
Directions
- Take 30 drops orally twice daily or as directed by a healthcare professional.
- Consult a physician for use in children under 12 years of age or if symptoms worsen or persist.
OTHER SAFETY INFORMATION
Other information
- Store at room temperature out of direct sunlight.
- Do not use if neck wrap is broken or missing.
INACTIVE INGREDIENT SECTION
Inactive ingredients
Ethyl Alcohol, Glycerin, Purified Water.
OTC - QUESTIONS SECTION
Distributed by
Energetix Corp.
Dahlonega, GA 30533
Questions? Comments?
800.990.7085
OTC - PURPOSE SECTION
Migrating pains, skin eruptions, fatigue, swollen glands.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
energetix
Lymph-Tone II
Homeopathic Remedy
Migrating pains, skin eruptions, fatigue, swollen glands.
2 fl oz (59.1 mL) / 15% Ethyl Alcohol
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 64578-0112-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-f47b-f424-e053-dadaa90a57ce | Lymph-Tone II |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 64578-0112-1 | Lymph ToneII | 59.1 mL in 1 BOTTLE, DROPPER | LIQUID | 59.1 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 64578-0112 | LYMPH TONE II (AESCULUS HIPPOCASTANUM, AZADIRACHTA INDICA, BARYTA CARBONICA, BERBERIS VULGARIS, BOLDO, BUFO RANA, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, COENZYME A, COLLINSONIA CANADENSIS, ECHINACEA (ANGUSTIFOLIA), FERRUM PHOSPHORICUM, GLANDULA SUPRARENALIS SUIS, HYPOTHALAMUS, KREOSOTUM, NADIDUM, NATRUM MURIATICUM, PHOSPHORUS, PHYTOLACCA DECANDRA, PINUS SYLVESTRIS, PITUITARUM POSTERIUM (BOVINE), PIX LIQUIDA, PULSATILLA (VULGARIS), SILICEA, STILLINGIA SYLVATICA, THUJA OCCIDENTALIS) LIQUID [ENERGETIX CORP] | 3 | Legacy NDC, 1 package rows | 20170105_aad73ace-5259-46c1-8aec-bf2a3b5bcf03.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| AZADIRACHTA INDICA BARK | ACTIVE INGREDIENT | G580B439YI | 1 | |
| BARIUM CARBONATE | ACTIVE INGREDIENT | 6P669D8HQ8 | 1 | |
| BERBERIS VULGARIS ROOT BARK | ACTIVE INGREDIENT | 1TH8Q20J0U | 1 | |
| BOS TAURUS HYPOTHALAMUS | ACTIVE INGREDIENT | S6G2NLH4Y7 | 1 | |
| BUFO BUFO CUTANEOUS GLAND | ACTIVE INGREDIENT | Q59QU6N72Q | 1 | |
| COENZYME A | ACTIVE INGREDIENT | SAA04E81UX | 1 | |
| COLLINSONIA CANADENSIS ROOT | ACTIVE INGREDIENT | O2630F3XDR | 1 | |
| ECHINACEA ANGUSTIFOLIA | ACTIVE INGREDIENT | VB06AV5US8 | 1 | |
| FERRUM PHOSPHORICUM | ACTIVE INGREDIENT | 91GQH8I5F7 | 1 | |
| HORSE CHESTNUT | ACTIVE INGREDIENT | 3C18L6RJAZ | 1 | |
| NADIDE | ACTIVE INGREDIENT | 0U46U6E8UK | 1 | |
| OYSTER SHELL CALCIUM CARBONATE, CRUDE | ACTIVE INGREDIENT | 2E32821G6I | 1 | |
| PEUMUS BOLDUS LEAF | ACTIVE INGREDIENT | Q4EWM09M3O | 1 | |
| PHOSPHORUS | ACTIVE INGREDIENT | 27YLU75U4W | 1 | |
| PHYTOLACCA AMERICANA ROOT | ACTIVE INGREDIENT | 11E6VI8VEG | 1 | |
| PINE TAR | ACTIVE INGREDIENT | YFH4WC535J | 1 | |
| PINUS SYLVESTRIS LEAFY TWIG | ACTIVE INGREDIENT | Q1RGP4UB73 | 1 | |
| PULSATILLA VULGARIS | ACTIVE INGREDIENT | I76KB35JEV | 1 | |
| SILICON DIOXIDE | ACTIVE INGREDIENT | ETJ7Z6XBU4 | 1 | |
| SODIUM CHLORIDE | ACTIVE INGREDIENT | 451W47IQ8X | 1 | |
| STILLINGIA SYLVATICA ROOT | ACTIVE INGREDIENT | QBR70R4FBK | 1 | |
| SUS SCROFA ADRENAL GLAND | ACTIVE INGREDIENT | 398IYQ16YV | 1 | |
| SUS SCROFA PITUITARY GLAND | ACTIVE INGREDIENT | E8S87O660T | 1 | |
| THUJA OCCIDENTALIS LEAFY TWIG | ACTIVE INGREDIENT | 1NT28V9397 | 1 | |
| TRIBASIC CALCIUM PHOSPHATE | ACTIVE INGREDIENT | 91D9GV0Z28 | 1 | |
| WOOD CREOSOTE | ACTIVE INGREDIENT | 3JYG22FD73 | 1 | |
| AZADIRACHTA INDICA BARK | ACTIVE MOIETY | G580B439YI | 1 | |
| BARIUM CATION | ACTIVE MOIETY | V645272HLN | 1 | |
| BERBERIS VULGARIS ROOT BARK | ACTIVE MOIETY | 1TH8Q20J0U | 1 | |
| BOS TAURUS HYPOTHALAMUS | ACTIVE MOIETY | S6G2NLH4Y7 | 1 | |
| BUFO BUFO CUTANEOUS GLAND | ACTIVE MOIETY | Q59QU6N72Q | 1 | |
| CALCIUM CATION | ACTIVE MOIETY | 2M83C4R6ZB | 1 | |
| CHLORIDE ION | ACTIVE MOIETY | Q32ZN48698 | 1 | |
| COENZYME A | ACTIVE MOIETY | SAA04E81UX | 1 | |
| COLLINSONIA CANADENSIS ROOT | ACTIVE MOIETY | O2630F3XDR | 1 | |
| COLLOIDAL SILICON DIOXIDE | ACTIVE MOIETY | ETJ7Z6XBU4 | 1 | |
| ECHINACEA ANGUSTIFOLIA | ACTIVE MOIETY | VB06AV5US8 | 1 | |
| FERROSOFERRIC PHOSPHATE | ACTIVE MOIETY | 91GQH8I5F7 | 1 | |
| HORSE CHESTNUT | ACTIVE MOIETY | 3C18L6RJAZ | 1 | |
| NADIDE | ACTIVE MOIETY | 0U46U6E8UK | 1 | |
| OYSTER SHELL CALCIUM CARBONATE, CRUDE | ACTIVE MOIETY | 2E32821G6I | 1 | |
| PEUMUS BOLDUS LEAF | ACTIVE MOIETY | Q4EWM09M3O | 1 | |
| PHOSPHORUS | ACTIVE MOIETY | 27YLU75U4W | 1 | |
| PHYTOLACCA AMERICANA ROOT | ACTIVE MOIETY | 11E6VI8VEG | 1 | |
| PINE TAR | ACTIVE MOIETY | YFH4WC535J | 1 | |
| PINUS SYLVESTRIS LEAFY TWIG | ACTIVE MOIETY | Q1RGP4UB73 | 1 | |
| PULSATILLA VULGARIS | ACTIVE MOIETY | I76KB35JEV | 1 | |
| STILLINGIA SYLVATICA ROOT | ACTIVE MOIETY | QBR70R4FBK | 1 | |
| SUS SCROFA ADRENAL GLAND | ACTIVE MOIETY | 398IYQ16YV | 1 | |
| SUS SCROFA PITUITARY GLAND | ACTIVE MOIETY | E8S87O660T | 1 | |
| THUJA OCCIDENTALIS LEAFY TWIG | ACTIVE MOIETY | 1NT28V9397 | 1 | |
| WOOD CREOSOTE | ACTIVE MOIETY | 3JYG22FD73 | 1 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Products#
Every source-derived product name is available through these pages.
- Lymph Tone II
- Aesculus hippocastanum, Azadirachta indica, Baryta carbonica, Berberis vulgaris, Boldo, Bufo rana, Calcarea carbonica, Calcarea phosphorica, Coenzyme A, Collinsonia canadensis, Echinacea (Angustifolia), Ferrum phosphoricum, Glandula suprarenalis suis, Hypothalamus, Kreosotum, Nadidum, Natrum muriaticum, Phosphorus, Phytolacca decandra, Pinus sylvestris, Pituitarum posterium (Bovine), Pix liquida, Pulsatilla (Vulgaris), Silicea, Stillingia sylvatica, Thuja occidentalis
- HORSE CHESTNUT
- AZADIRACHTA INDICA BARK
- BARIUM CARBONATE
- BARIUM CATION
- BERBERIS VULGARIS ROOT BARK
- PEUMUS BOLDUS LEAF
- BUFO BUFO CUTANEOUS GLAND
- OYSTER SHELL CALCIUM CARBONATE, CRUDE
- TRIBASIC CALCIUM PHOSPHATE
- CALCIUM CATION
- COENZYME A
- COLLINSONIA CANADENSIS ROOT
- ECHINACEA ANGUSTIFOLIA
- FERRUM PHOSPHORICUM
- SUS SCROFA ADRENAL GLAND
- BOS TAURUS HYPOTHALAMUS
- WOOD CREOSOTE
- NADIDE
- SODIUM CHLORIDE
- CHLORIDE ION
- PHOSPHORUS
- PHYTOLACCA AMERICANA ROOT
- PINUS SYLVESTRIS LEAFY TWIG
- BOS TAURUS PITUITARY GLAND
- PINE TAR
- PULSATILLA VULGARIS
- SILICON DIOXIDE
- STILLINGIA SYLVATICA ROOT
- THUJA OCCIDENTALIS LEAFY TWIG
- WATER
- ALCOHOL
- GLYCERIN
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 64578-0112 | 64578-0112-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYSTEM / IONTOPHORESIS | 168.1 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAVENOUS | 6405 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | MOUTHWASH / BUCCAL | 200 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / RECTAL | 0.35 %v/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SHAMPOO / TOPICAL | 5 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE / ORAL | 3487 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / DENTAL | 20 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / OPHTHALMIC | 58 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / NASAL | 10 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | JELLY / VAGINAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / NASAL | 10 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / OPHTHALMIC | 12 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / BUCCAL | 679 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 35.75 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / TOPICAL | 1720 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM, AUGMENTED / TOPICAL | 55 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / SUBCUTANEOUS | 6.1 %v/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / SUBCUTANEOUS | 15 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, LIQUID FILLED / ORAL | 185 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAVENOUS | 33750 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, EMULSION / INTRAVENOUS | 520 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 225 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LOTION / TOPICAL | 3990 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SWAB / TOPICAL | 2250 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | OINTMENT / TOPICAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / TOPICAL | 561 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TOPICAL | 2445 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / VAGINAL | 60 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPONGE / TOPICAL | 2 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / ORAL | 300 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / DENTAL | 1.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / INTRAVENOUS | 4000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / SUBCUTANEOUS | 149 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | JELLY / VAGINAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / DENTAL | 12.8 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / AURICULAR (OTIC) | 0.05 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, EXTENDED RELEASE / ORAL | 7 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / RECTAL | 898 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAMUSCULAR | 15 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / NASAL | 10 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CONCENTRATE / ORAL | 1800 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, COATED / ORAL | 14.21 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | EMULSION / INTRAVENOUS | 2.2 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / RESPIRATORY (INHALATION) | 5 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TRANSDERMAL | 7360 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVESICAL | 7892 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | AEROSOL, FOAM / TOPICAL | 21 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / VAGINAL | 227.9 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVASCULAR | 100 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / DENTAL | 15 %w/v |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 5072c593-6c52-4f5f-807a-cfb360fd9ee9 | aad73ace-5259-46c1-8aec-bf2a3b5bcf03 | 2017-01-04 | Warnings | 5072c593-6c52-4f5f-807a-cfb360fd9ee9 aad73ace-5259-46c1-8aec-bf2a3b5bcf03 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.